Table 1 Subject demographics
From: Multi-omic characterization of pediatric ARDS via nasal brushings
PARDS (n = 39) | Control (n = 23) | p-value | ||
|---|---|---|---|---|
Age | Median (IQR) | 6.8 (3.5 to 10.3) | 6.1 (1.3 to 11.2) | 0.471 |
Sex | Female | 17 (43.6) | 9 (39.1) | 0.794 |
Male | 22 (56.4) | 14 (60.9) | ||
Race | Non-White | 12 (30.8) | 3 (13.0) | 0.138 |
White | 27 (69.2) | 20 (87.0) | ||
Genetic Synd. or D.D | False | 18 (46.2) | 20 (87.0) | 0.003 |
True | 21 (53.8) | 3 (13.0) | ||
Baseline lung disease | False | 26 (66.7) | 14 (60.9) | 0.784 |
True | 13 (33.3) | 9 (39.1) | ||
Baseline kidney or liver disease | False | 34 (87.2) | 21 (91.3) | 1 |
True | 5 (12.8) | 2 (8.7) | ||
Immunocompromised | False | 27 (69.2) | 22 (95.7) | 0.021 |
True | 12 (30.8) | 1 (4.3) | ||
Highest PELOD2 | Median (IQR) | 13.0 (11.0 to 15.5) | 8.0 (6.5 to 10.0) | < 0.001 |
Highest PARDS category | None | 1 (2.6)# | 22 (95.8) | < 0.001 |
Mild | 10 (25.6) | 1 (4.2)## | ||
Moderate | 16 (41.0) | 0 (0.0) | ||
Severe | 12 (30.8) | 0 (0.0) | ||
Viral infection | False | 20 (51.3) | 23 (100) | < 0.001 |
True | 19 (48.7) | |||
Any corticosteroids | No | 15 (38.5) | 16 (69.6) | 0.034 |
Yes | 24 (61.5) | 7 (30.4) | ||
Ventilator free days | Median (IQR) | 19.4 (13.0 to 22.1) | 0.0 (0.0 to 20.6) | 0.016 |
PICU days | Median (IQR) | 17.0 (10.0 to 29.5) | 5.0 (2.0 to 7.5) | < 0.001 |
Hospital days | Median (IQR) | 29.0 (14.0 to 60.0) | 14.0 (5.0 to 19.0) | < 0.001 |
Mortality | Died | 7 (17.9) | 0.04 | |
Survived | 32 (82.1) | 23 (100.0) |